What is hot at ESC 2023? In this episode of View of the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, NL) preview the hot line and late-breaking data presented at ESC Congress 2023. With their dynamic analysis, they place these highly anticipated trials within a context, highlighting the real-world implications tied to the data releases. Top trials covered 00:31: ECLS-SHOCK: Extracorporeal life support in cardiogenic shock 03:25: EARLY-UNLOAD: Early left ventricular unloading after extracorporeal membrane oxygenation 05:21: ARREST: Expedited transfer to a cardiac arrest center for OHCA 07:33: GUIDE-DES: QCA versus IVUS guidance for DES implantation 10:38: ILUMIEN IV: OCT versus angiography 13:11: OCTOBER: OCT-guided or angiography-guided PCI in complex bifurcation lesions 16:14: OCTIVUS: OCT- versus IVUS-guided PCI 18:27: FIRE: Functional versus culprit-only revascularization in elderly patients with myocardial Infarction and multivessel disease 19:50: OCT vs IVUS vs Angiography Guidance 20:11: Meta-analysis of iFR-SWEDEHEART and DEFINE FLAIR 20:53: HEART-FID: Ferric carboxymaltose in heart failure with iron deficiency 22:14: STOPDAPT-3: An aspirin-free antithrombotic strategy for percutaneous coronary intervention 24:50: MULTISTARTS AMI: Multivessel immediate versus staged revascularization in STEMI 26:20: NOTION: The nordic aortic valve intervention trial Mark your calendar for our ESC Congress coverage starting August 25. Interviews, discussions and insights live from Amsterdam.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related